We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Morso London is a modern community-centred restaurant that serves hand-crafted freshly made pasta and Italian bites with grappa-based cocktails. Launched in June 2018, the restaurant is created by a team of industry veterans. Paolo Vernetti is the Co-founder, head chef and CEO of Morso. Since Dec 2018, Morso has been TripAdvisor's Top 50 restaurant. The restaurant has received more than 100 5 star reviews. Morso was covered by Fay Maschler’s “Week in Food”, The Upcoming, The Infatuation and many other important food/media publications. Morso has achieved a 3x weekly sales growth from June 2018 to Jan 2019. It is achieving a positive site EBITDA on the 6th month of trading. Morso is planning to grow by opening two more sites in 2019.
days to go: Expired investment: £99,950
Bookblock is a custom gifting platform that makes buying gifts and sending cards easier and affordable for everyone. In 2014, it began as a design-led gift manufacturer taking the client's idea and turning it into a premium bespoke product. Since then, it has seen over £5.4m of sales and a profit of £348k in FY 2018. Since its last fundraise, Bookblock has grown into a £2m revenue business. Bookblock has made manufacturing accessible by introducing 3D technology that simplified intricate manufacturing processes. Since launch, it has implemented many functionalities and improvements, and are now ready for a marketing push.
days to go: Expired investment: £169,670
Yumbles is a leading UK online marketplace for artisan food. It currently connects over 600 independent food makers directly with consumers. The company is targeting the UK’s estimated £10bn+ UK Speciality Food & Drink market, having seen £1m+ sales in the last 12 months resulting in £400k+ revenue.
days to go: Expired investment: £262,080
Hawkens Gingerbread is a bakery that makes gingerbread products that are diverse, rich in heritage, delicious, and high in quality. It has spent three years in a start-up phase and now targets a three-year phase of stage one growth. Currently, its facility can bake up to 80,000 units of gingerbread each month. Since 2017, it is consistently producing a 65% average gross profit margin across its B2C and B2B markets. This company has been growing for three years, and in the financial year 2019, its revenue grew 108% to £43k (£25k profit). Its online sales are displaying a strong flow in the upwards direction. Fund raised will enable it to get in front of a much wider audience and bring the necessary skills into the business.
days to go: Expired investment: £67,110
Njori is a company that has created an accurate, multi-functional cooker that can be stored on a bookshelf alongside cookbooks. The cooker uses integrated sensors and accessories to monitor and regulate the cooking process. It's built-in scales helps a user measure ingredients before and during the cooking process. The scale function also enables the user to reduce food by a set weight or percentage. The company aims to be a disruptor in the global portable induction cooker market that is set to be worth £4.5 billion by 2022. Njori has filed UK patents & is building its supply chain in China. It will use the investment to finish development and bring the final product to market.

Pitch Rated

77%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £236,797
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph